Dr. Wallace is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-275-5830
Education & Training
- University of RochesterFellowship, Hematology and Medical Oncology, 2020 - 2023
- University of RochesterResidency, Internal Medicine, 2016 - 2019
- SUNY Upstate Medical UniversityClass of 2016
Certifications & Licensure
- NY State Medical License 2017 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- ALK-rearranged CD30-positive poorly differentiated lung adenocarcinoma, mimicking anaplastic large-cell lymphoma.Giby V George, Danielle S Wallace, Ying Wang, John Carney, Murad Elsadawi
Histopathology. 2024-04-01 - Phase 2 trial of umbralisib, ublituximab, and venetoclax in patients with relapsed/refractory mantle cell lymphoma.Danielle S Wallace, Chris Rowland, Brian T Hill, Andrea M Baran, Carla Casulo
Leukemia & Lymphoma. 2023-09-01 - 4 citationsAcalabrutinib and high-frequency low-dose subcutaneous rituximab for initial therapy of chronic lymphocytic leukemia.Danielle S Wallace, Clive S Zent, Andrea M Baran, Patrick M Reagan, Carla Casulo
Blood Advances. 2023-06-13
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: